Perspectives on the prevention and treatment of infection for orthopedic tissue engineering applications

Chinese Science Bulletin

Volumn 58, Issue 35, 2013, Pages 4342-4348

  Shah, Sarita R ^a   Kasper, F Kurtis ^a   Mikos, Antonios G ^a  

^a Rice University   (United States)

Author keywords

antibiotic delivery; antifouling agents; infection; tissue engineering

Indexed keywords

EID: 84887616753     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1007/s11434-013-5780-8     Document Type: Review

References (65)

1. Moyad T F, Thornhill T, Estok D. Evaluation and management of the infected total hip and knee. Orthopedics, 2008, 31: 581-590.
2. Hanssen A D, Rand J A. Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. Instr Course Lect, 1999, 48: 111-122.
3. Scott R D. National Center for Preparedness, Detection, and Control of Infectious Diseases (Centers for Disease Control and Prevention). Division of Healthcare Quality Promotion. The direct medical costs of healthcare-associated infections in US. hospitals and the benefits of prevention, 2009.
4. Gristina A G. Biomaterial-centered infection: Microbial adhesion versus tissue integration. Science, 1987, 237: 1588-1595.
5. Gristina A G, Shibata Y, Giridhar G, et al. The glycocalyx, biofilm, microbes, and resistant infection. Semin Arthroplasty, 1994, 5: 160-170.
6. Bayston R, Ashraf W, Barker-Davies R, et al. Biofilm formation by propionibacterium acnes on biomaterials in vitro and in vivo: Impact on diagnosis and treatment. J Biomed Mater Res, 2007, 81A: 705-709.
7. Spellberg B, Guidos R, Gilbert D, et al. The epidemic of antibiotic-resistant infections: A call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis, 2008, 46: 155-164.
8. Somayaji S N, Ritchie S, Sahraei M, et al. Staphylococcus aureus induces expression of receptor activator of NF-B ligand and prostaglandin E2 in infected murine osteoblasts. Infect Immun, 2008, 76: 5120-5126.
9. Tabel G, Hoa N T, Tarnawski A, et al. Helicobacter pylori infection inhibits healing of the wounded duodenal epithelium in vitro. J Lab Clin Med, 2003, 142: 421-430.
10. Schierle C F, De la Garza M, Mustoe T A, et al. Staphylococcal biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound model. Wound Repair Regen, 2009, 17: 354-359.
11. Guo S, DiPietro L A. Factors affecting wound healing. J Dent Res, 2010, 89: 219-229.
12. Bost K L, Ramp W K, Nicholson N C, et al. Staphylococcus aureus infection of mouse or human osteoblasts induces high levels of interleukin-6 and interleukin-12 production. J Infect Dis, 1999, 180: 1912-1920.
13. Penn-Barwell J G, Murray C K, Wenke J C. Early antibiotics and debridement independently reduce infection in an open fracture model. J Bone Joint Surg Br Vol, 2012, 94B: 107-112.
14. Koyonos L, Zmistowski B, Della Valle C J, et al. Infection control rate of irrigation and débridement for periprosthetic joint infection. Clin Orthop Rel Res, 2011, 469: 3043-3048.
15. Odum S M, Fehring T K, Lombardi A V, et al. Irrigation and debridement for periprosthetic infections. J Arthroplasty, 2011, 26: 114-118.
16. Fehring T K, Odum S M, Berendm K R, et al. Failure of irrigation and débridement for early postoperative periprosthetic infection. Clin Orthop Rel Res, 2013, 471: 250-257.
17. Rathbone C R, Cross J D, Brown K V, et al. Effect of various concentrations of antibiotics on osteogenic cell viability and activity. J Orthop Res, 2011, 29: 1070-1074.
18. Wachol-Drewek Z Z, Pfeiffer M M, Schol E E. Comparative investigation of drug delivery of collagen implants saturated in antibiotic solutions and a sponge containing gentamicin. Biomaterials, 1996, 17: 1733-1738.
19. Noel S P, Courtney H, Bumgardner J D, et al. Chitosan films: A potential local drug delivery system for antibiotics. Clin Orthop Rel Res, 2008, 466: 1377-1382.
20. Mi F L, Wu Y B, Shyu S S, et al. Control of wound infections using a bilayer chitosan wound dressing with sustainable antibiotic delivery. J Biomed Mater Res, 2001, 59: 438-449.
21. Kent M E, Rapp R P, Smith K M. Antibiotic beads and osteomyelitis: Here today, what's coming tomorrow? Orthopedics, 2006, 29: 599-603.
22. Wenke J C, Owens B D, Svoboda S J, et al. Effectiveness of commercially-available antibiotic-impregnated implants. J Bone Joint Surg Br Vol, 2006, 88: 1102-1104.
23. Anagnostakos K, Hitzler P, Pape D, et al. Persistence of bacterial growth on antibiotic-loaded beads: Is it actually a problem? Acta Orthop, 2008, 79: 302-307.
24. Turner T M, Urban R M, Hall D J, et al. Local and systemic levels of tobramycin delivered from calcium sulfate bone graft substitute pellets. Clin Orthop Rel Res, 2005, 437: 97-104.
25. Cai X, Han K, Cong X, et al. The use of calcium sulfate impregnated with vancomycin in the treatment of open fractures of long bones: A preliminary study. Orthopedics, 2010, 33: 152-157.
26. Helgeson M D, Potter B K, Tucker C J, et al. Antibiotic-impregnated calcium sulfate use in combat-related open fractures. Orthopedics, 2009, 32: 323.
27. Shi M, Kretlow J D, Nguyen A, et al. Antibiotic-releasing porous polymethylmethacrylate constructs for osseous space maintenance and infection control. Biomaterials, 2010, 31: 4146-4156.
28. Buschle-Diller G, Cooper J, Xie Z, et al. Release of antibiotics from electrospun bicomponent fibers. Cellulose, 2007, 14: 553-562.
29. Özalp Y, Özdemir N, Kocagöz S, et al. Controlled release of vancomycin from biodegradable microcapsules. J Microencapsul, 2001, 18: 89-110.
30. Pillai R R, Somayaji S N, Rabinovich M, et al. Nafcillin-loaded PLGA nanoparticles for treatment of osteomyelitis. Biomed Mater, 2008, 3: 034114.
31. Ambrose C G, Gogola G R, Clyburn T A, et al. Antibiotic microspheres: Preliminary testing for potential treatment of osteomyelitis. Clin Orthop Rel Res, 2003, 415: 279-285.
32. Ramchandani M, Robinson D. In vitro and in vivo release of ciprofloxacin from PLGA 50: 50 implants. J Control Release, 2998, 54: 167-175.
33. Rui J, Dadsetan M, Runge M B, et al. Controlled release of vascular endothelial growth factor using poly-lactic-co-glycolic acid microspheres: In vitro characterization and application in polycaprolactone fumarate nerve conduits. Acta Biomater, 2012, 8: 511-518.
34. Ruhé P Q, Boerman O C, Russel F G, et al. Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. J Control Release, 2005, 106: 162-171.
35. Klasen H J. Historical review of the use of silver in the treatement of burns. I. Early uses. Burns, 2000, 26: 117-130.
36. Huh A J, Kwon Y J. "Nanoantibiotics": A new paradigm for treating infectious diseases using nanomaterials in the antibiotic resistant era. J Control Release, 2011, 156: 128-145.
37. Davis I J, Richards H, Mullany P. Isolation of silver- and antibiotic-resistant Enterobacter cloacae from teeth. Oral Microbiol Immunol, 2005, 20: 191-194.
38. Feng Q L, Wu J, Chen G Q, et al. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater, 2000, 52: 662-668.
39. Gong P, Li H, He X, et al. Preparation and antibacterial activity of Fe3O4@Ag nanoparticles. Nanotechnology, 2007, 18: 285604.
40. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv, 2009, 27: 76-83.
41. Grewal J S, Tiwari R P. Resistance to metal ions and antibiotics in Escherichia coli isolated from foodstuffs. J Med Microbiol, 1990, 32: 223-226.
42. Choi S, Isaacs A, Clements D, et al. De novo design and in vivo activity of conformationally restrained antimicrobial peptides. Proc Natl Acad Sci USA, 2009, 106: 6968-6973.
43. Liu D, Choi S, Chen B, et al. Nontoxic membrane-active antimicrobial arylamide oligomers. Angew Chem Int Ed, 2004, 43: 1158-1162.
44. Kazemzadeh-Narbat M, Kindrachuk J, Duan K, et al. Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant associated infections. Biomaterials, 2010, 31: 9519-9526.
45. Stallman H P, Faber C, Bronckers A L J J, et al. Osteomyelitis prevention in rabbits using antimicrobial peptide hLF1-11- or gentamicin-containing calcium phosphate cement. J Antimicrob Chemother, 2004, 54: 472-476.
46. Stallman H P, de Roo R, Faber C, et al. In vivo release of the antimicrobial peptide hlf1-11 from calcium phosphate cement. J Orthop Res, 2008, 26: 531-538.
47. Shukla A, Fleming K E, Chuang H F, et al. Controlling the release of peptide antimicrobial agents from surfaces. Biomaterials, 2010, 31: 2348-2357.
48. Zasloff M. Antimicrobial peptides of multicellular origin. Nature, 2002, 415: 389-395.
49. Bell G, Gouyon P H. Arming the enemy: The evolution of resistance development and persistence. Microbiology, 2003, 149: 1367-1375.
50. Perron G G, Zasloff M, Bell G. Experimental evolution of resistance to an antimicrobial peptide. Proc R Soc B-Biol Sci, 2006, 273: 251-256.
51. Anaya-López J L, López-Meza J E, Ochoa-Zarzosa A. Bacterial resistance to cationic antimicrobial peptides. Crit Rev Microbiol, 2012, 38: 1-16.
52. Neut D, van de Belt H, Stokroos I, et al. Biomaterial-associate infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. J Antimicrob Chemother, 2001, 47: 885-891.
53. Anagnostakos K, Hitzler P, Pape D, et al. Persistence of bacterial growth on antibiotic-loaded beads: Is it actually a problem? Acta Orthop, 2008, 79: 302-307.
54. Olson M E, Ceri H, Morck D W, et al. Biofilm bacteria: Formation and comparative susceptibility to antibiotics. Can J Vet Res, 2002, 66: 86-92.
55. Davies D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov, 2003, 2: 114-122.
56. Kirby A E, Garner K, Levin B R. The relative contributions of physical structure and cell density to the antibiotic susceptibility of bacteria in biofilms. Antimicrob Agents Chemother, 2012, 56: 2967-2975.
57. Davies D G, Marques C N. A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J Bacteriol, 2009, 191: 1393-1403.
58. Jennings J A, Courtney H S, Haggard W O. Cis-2-decenoic acid inhibits s. aureus growth and biofilm in vitro: A pilot study. Clin Orthop Rel Res, 2012, 470: 2663-2670.
59. Lü H, Zhang S, Wang B, et al. Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release, 2006, 114: 100-109.
60. Nagamune H, Maeda T, Ohkura K, et al. Evaluation of the cytotoxic effects of bis-quaternary ammonium antimicrobial reagents on human cells. Toxicol In Vitro, 2000, 14: 139-147.
61. Cheng G, Xue H, Zhang Z, et al. A switchable biocompatible polymer surface with self-sterilizing and nonfouling capabilities. Angew Chem Int Ed, 2008, 47: 8831-8834.
62. Tan H, Peng Z, Li Q, et al. The use of quaternised chitosan-loaded PMMA to inhibit biofilm formation and downregulate the virulence-associated gene expression of antibiotic-resistant staphylococcus. Biomaterials, 2010, 33: 365-377.
63. Hochbaum A I, Kolodkin-Gal I, Foulston L, et al. Inhibitory effects of D-amino acids on staphylococcus aureus biofilm development. J Bacteriol, 2011, 193: 5616-5622.
64. Kolodkin-Gal I, Romero D, Cao S, et al. D-amino acids trigger biofilm disassembly. Science, 2010, 328: 627-629.
65. Xu H, Liu Y. D-amino acid mitigated membrane biofouling and promoted biofilm detachment. J Membr Sci, 2011, 376: 266-274.